UDP acts as a growth factor for vascular smooth muscle cells by activation of P2Y6 receptors

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 282, Issue 2 51-2, 2002, Pages

  Hou, Mingyan ^a   Kendall Harden, T ^b   Kuhn, Cynthia M ^c   Baldetorp, Bo ^e   Lazarowski, Eduardo ^b   Pendergast, William ^d   Möller, Sebastian ^a   Edvinsson, Lars ^a   Erlinge, David ^e  

^a Department of Medicine   (Sweden)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Gene expression; Uridine 5 diphosphate

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ADENOSINE TRIPHOSPHATE; CYCLIC AMP DEPENDENT PROTEIN KINASE; GROWTH FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; HEXOKINASE; HYDROGEN; ICOSANOID; LEUCINE; MESSENGER RNA; PHOSPHOLIPASE C; PROTEIN KINASE C DELTA; PROTEIN TYROSINE KINASE; PURINE P2Y RECEPTOR; THYMIDINE; UNCLASSIFIED DRUG; URIDINE 5' O (2 THIODIPHOSPHATE); URIDINE DIPHOSPHATE; URIDINE TRIPHOSPHATE;

ANIMAL CELL; ANIMAL TISSUE; AORTA MEDIA; ARTICLE; CELL COUNT; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSFECTION; HALF LIFE TIME; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

EID: 0036084809     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00997.2000     Document Type: Article

References (40)

1. Potential signalling roles for UTP and UDP: Sources, regulation and release of uracil nucleotides
2. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
3. Expression of protein kinase C isoforms in smooth muscle cells in various states of differentiation
4. Statistical evaluation of cell kinetic data from DNA flow cytometry (FCM) by the EM algorithm
5. Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid with low S-phase fraction by flow cytometry
6. Cyclic AMP and tyrosine kinase cascades in the regulation of cellular function by P2Y nucleotide receptors
7. Molecular cloning and functional analysis of a novel P 2 nucleotide receptor
8. Metabolism of adenine nucleotides in human blood
9. Uridine and its nucleotides: Biological actions, therapeutic potentials
10. Extracellular ATP a growth factor for vascular smooth muscle cells
11. Phenotype changes of the vascular smooth muscle cell regulate P2 receptor expression as measured by quantitative RT-PCR
12. Mitogenic effects of ATP on vascular smooth muscle cells vs. other growth factors and sympathetic cotransmitters
13. Characterisation of an ATP receptor mediating mitogenesis in vascular smooth muscle cells
14. 4 nucleotide receptors are involved in the regulation of rat aortic smooth muscle cells by UTP and ATP
15. The potential for isoenzyme-selective modulation of protein kinase C
16. 2-receptor mRNA resulting in increased mitogenic response to UTP and ATP
17. 2 receptors in vascular smooth muscle cells
18. Endothelin-1 and angiotensin II act as progression but not competence growth factors in vascular smooth muscle cells
19. Pyrimidine nucleotide-stimulated thromboxane A 2 release from cultured glia
20. Quantitation of extracellular UTP using a sensitive enzymatic assay
21. Identification of an ecto-nucleoside diphosphokinase and its contribution to interconversion of P 2 receptor agonists
22. 2U-purinoreceptors
23. Regulation of tyrosine kinase cascades by G-protein-coupled receptors
24. The stable pyrimidines UDPβS and UTPγS discriminate between the P 2 receptors that mediate vascular contraction and relaxation of the rat mesenteric artery
25. Extracellular uridine nucleotides initiate cytokine production by murine dendritic cells
26. Selective inhibition of protein kinase C isoenzymes by the indolocarbazole Go 6976
27. P 2U purinergic activation leads to the cell cycle progression from the G1 to the S and M phases but not from the GO to G1 phase in vascular smooth muscle cells in primary culture
28. Uridine nucleotides selective of three phospholipase C-activating P2 receptors: Identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor
29. P2-purinergic receptors are coupled to two signal transduction systems leading to inhibition of cAMP generation and to production of inositol triphosphate in rat hepatocytes
30. Receptors for purines and pyrimidines
31. NIH Image: A public domain image processing program for the Macintosh
32. Slow desensitization of the human P 2Y6 receptor
33. Atherosclerosis an inflammatory disease
34. Uptake and flow-induced release of uridine nucleotides from isolated vascular endothelial cells
35. Second messenger cascade specificity and pharmacological selectivity of the human P2Y1-purinoceptor
36. Neuropeptide Y stimulates DNA synthesis in vascular smooth muscle cells
37. Activation of P2Y2 receptors by UTP and ATP stimulates mitogen-activated kinase activity through a pathway that involves related adhesion focal tyrosine kinase and protein kinase C
38. P2 purinoceptor-mediated inhibition of cyclic AMP accumulation in NG108-15 cells
39. Isoenzyme specificity of bisindolylmaleimides, a selective inhibitor of protein kinase C
40. Role of action potentials and calcium influx in ATP- and UDP-induced noradrenaline release from rat cultured sympathetic neurones